IMS Health (IMS) Tops Q1 EPS by 7c

IMS Health (NYSE: IMS) reported Q1 EPS of $0.39, $0.07 better than the analyst estimate of $0.32. Revenue for the quarter came in at $632 million versus the consensus estimate of $626.89 million.

For earnings history and earnings-related data on IMS Health (IMS) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c